Quanta Services Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Quanta Services Inc trades at $647.65 (market cap $99.31B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.76B). The key difference: Quanta Services Inc is far larger — about 56.4× Vir Biotechnology Inc. Common Stock's market cap, and Quanta Services Inc pays a 0.07% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quanta Services Inc for 62 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| PWR | VIR | |
|---|---|---|
Market Cap | $99.31B | $1.76B |
Volume | 1,067,966 | 2,764,948 |
Sector | Industrials | Health |
52-Week High | $785.24 | $11.78 |
52-Week Low | $412.21 | $5.12 |
Typical Hold Time | 62 Days | 0 Days |
Enterprise Value | $105.40B | $1.32B |
Dividend Yield | 0.07% | — |
Signals from Pluang's Aura AI — not financial advice
PWR trades at $688.88, down 0.85% on the day, with a bullish technical outlook supported by moving averages and a strong $53B backlog. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Revenue growth is robust, rising from $17.1B in 2022 to $28.5B in 2025, though valuation multiples like a P/E of 78.82 are elevated. Analyst sentiment is overwhelmingly positive, with 27 buy ratings and a consensus price target of $802.08, implying significant upside.
The outlook for PWR is favorable, driven by infrastructure demand and AI-related data center investments, but risks include high valuation sensitivity, execution challenges from rapid growth, and macroeconomic pressures on capital spending. The stock's near-term performance will hinge on Q3 earnings delivery and margin sustainability.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →